Innate immune cell-derived microparticles facilitate hepatocarcinoma metastasis by transferring integrin αmβ2 to tumor cells

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3453-3461

  Ma, Jingwei ^a,b   Cai, Wenqian ^a   Zhang, Yi ^a   Huang, Chunmei ^a   Zhang, Huafeng ^a   Liu, Jing ^a   Tang, Ke ^a   Xu, Pingwei ^a   Katirai, Foad ^a   Zhang, Jianmin ^b   He, Wei ^b   Ye, Duyun ^a   Shen, Guan Xin ^a   Huang, Bo ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD11B ANTIGEN; CD18 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FLOW CYTOMETRY; GLUCOSE METABOLISM; IMMUNE CELL DERIVED MICROPARTICLES; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LIVER CELL CARCINOMA; LIVER METASTASIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TUMOR CELL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNITY, INNATE; LIVER NEOPLASMS; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM INVASIVENESS;

EID: 84884269031     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300171     Document Type: Article

References (46)

1. Talmadge, J. E., M. Donkor, and E. Scholar. 2007. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev. 26: 373-400.
2. Qian, B. Z., and J. W. Pollard. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
3. DeNardo, D. G., M. Johansson, and L. M. Coussens. 2008. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev. 27: 11-18.
4. Shaked, Y., and E. E. Voest. 2009. Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil? Biochim. Biophys. Acta 1796: 1-4.
5. Murdoch, C., M. Muthana, S. B. Coffelt, and C. E. Lewis. 2008. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8: 618-631.
6. Liu, J., Y. Zhang, J. Zhao, Z. S. Yang, D. P. Li, F. Katirai, and B. Huang. 2011. Mast cell: insight into remodeling a tumor microenvironment. Cancer Metastasis Rev. 30: 177-184.
7. Joyce, J. A., and J. W. Pollard. 2009. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9: 239-252.
8. Kaplan, R. N., R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, et al. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
9. Kaplan, R. N., B. Psaila, and D. Lyden. 2006. Bone marrow cells in the 'premetastatic niche': within bone and beyond. Cancer Metastasis Rev. 25: 521-529.
10. McIntyre, T. M., S. M. Prescott, A. S. Weyrich, and G. A. Zimmerman. 2003. Cell-cell interactions: leukocyte-endothelial interactions. Curr. Opin. Hematol. 10: 150-158.
11. Smith, A., P. Stanley, K. Jones, L. Svensson, A. McDowall, and N. Hogg. 2007. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol. Rev. 218: 135-146.
12. Ross, G. D. 2002. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. Immunol. Res. 25: 219-227.
13. Pawelek, J., A. Chakraborty, R. Lazova, Y. Yilmaz, D. Cooper, D. Brash, and T. Handerson. 2006. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion? Contrib. Microbiol. 13: 138-155.
14. Lazova, R., A. Chakraborty, and J. M. Pawelek. 2011. Leukocyte-cancer cell fusion: initiator of the Warburg effect in malignancy? Adv. Exp. Med. Biol. 714: 151-172.
15. Pawelek, J. M., and A. K. Chakraborty. 2008. The cancer cell-leukocyte fusion theory of metastasis. Adv. Cancer Res. 101: 397-444.
16. Koido, S., E. Hara, S. Homma, K. Fujise, J. Gong, and H. Tajiri. 2007. Dendritic/ tumor fusion cell-based vaccination against cancer. Arch. Immunol. Ther. Exp. 55: 281-287.
17. Pluskota, E., N. M. Woody, D. Szpak, C. M. Ballantyne, D. A. Soloviev, D. I. Simon, and E. F. Plow. 2008. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood 112: 2327-2335.
18. Tang, K., J. Liu, Z. S. Yang, B. Zhang, H. F. Zhang, C. M. Huang, J. W. Ma, G. X. Shen, D. Y. Ye, and B. Huang. 2010. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis. Biochem. Biophys. Res. Commun. 400: 432-436.
19. Wolf, P. 1967. The nature and significance of platelet products in human plasma. Br. J. Haematol. 13: 269-288.
20. Hugel, B., M. C. Martínez, C. Kunzelmann, and J. M. Freyssinet. 2005. Membrane microparticles: two sides of the coin. Physiology 20: 22-27.
21. Ratajczak, J., M. Wysoczynski, F. Hayek, A. Janowska-Wieczorek, and M. Z. Ratajczak. 2006. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20: 1487-1495.
22. Mause, S. F., and C. Weber. 2010. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107: 1047-1057.
23. VanWijk, M. J., E. VanBavel, A. Sturk, and R. Nieuwland. 2003. Microparticles in cardiovascular diseases. Cardiovasc. Res. 59: 277-287.
24. Arnaout, M. A. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75: 1037-1050.
25. von Andrian, U. H., J. D. Chambers, L. M. McEvoy, R. F. Bargatze, K. E. Arfors, and E. C. Butcher. 1991. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc. Natl. Acad. Sci. USA 88: 7538-7542.
26. Tan, S. M. 2012. The leucocyte b2 (CD18) integrins: the structure, functional regulation and signalling properties. Biosci. Rep. 32: 241-269.
27. Lorusso, G., and C. Rüegg. 2008. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem. Cell Biol. 130: 1091-1103.
28. Steeg, P. S. 2006. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12: 895-904.
29. Chaffer, C. L., and R. A. Weinberg. 2011. A perspective on cancer cell metastasis. Science 331: 1559-1564.
30. Muller, P. A., K. H. Vousden, and J. C. Norman. 2011. p53 and its mutants in tumor cell migration and invasion. J. Cell Biol. 192: 209-218.
31. Micalizzi, D. S., S. M. Farabaugh, and H. L. Ford. 2010. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia 15: 117-134.
32. Kraljevic Pavelic, S., M. Sedic, H. Bosnjak, S. Spaventi, and K. Pavelic. 2011. Metastasis: new perspectives on an old problem. Mol. Cancer 10: 22.
33. Rachkovsky, M., S. Sodi, A. Chakraborty, Y. Avissar, J. Bolognia, J. M. McNiff, J. Platt, D. Bermudes, and J. Pawelek. 1998. Melanoma 3 macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis 16: 299-312.
34. Pawelek, J. M., and A. K. Chakraborty. 2008. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat. Rev. Cancer 8: 377-386.
35. Krajcovic, M., and M. Overholtzer. 2012. Mechanisms of ploidy increase in human cancers: a new role for cell cannibalism. Cancer Res. 72: 1596-1601.
36. White, E. 2007. Entosis: it's a cell-eat-cell world. Cell 131: 840-842.
37. Clarke, R. 2011. Cannibalism, cell survival, and endocrine resistance in breast cancer. Breast Cancer Res. 13: 311.
38. Al-Nedawi, K., B. Meehan, and J. Rak. 2009. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8: 2014-2018.
39. Townson, J. L., G. N. Naumov, and A. F. Chambers. 2003. The role of apoptosis in tumor progression and metastasis. Curr. Mol. Med. 3: 631-642.
40. Huang, B., J. Zhao, J. C. Unkeless, Z. H. Feng, and H. Xiong. 2008. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224.
41. Tang, K., Y. Zhang, H. F. Zhang, P. W. Xu, J. Liu, J. W. Ma, M. Lv, D. P. Li, F. Katirai, G. X. Shen, et al. 2012. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat. Commun. 3: 1282.
42. Ahn, G. O., D. Tseng, C. H. Liao, M. J. Dorie, A. Czechowicz, and J. M. Brown. 2010. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc. Natl. Acad. Sci. USA 107: 8363-8368.
43. van Spriel, A. B., J. H. Leusen, M. van Egmond, H. B. Dijkman, K. J. Assmann, T. N. Mayadas, and J. G. van de Winkel. 2001. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood 97: 2478-2486.
44. Solovjov, D. A., E. Pluskota, and E. F. Plow. 2005. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J. Biol. Chem. 280: 1336-1345.
45. Von Bubnoff, D., M. Scheler, H. Wilms, R. Fimmers, and T. Bieber. 2011. Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J. Immunol. 186: 6701-6709.
46. Liang, B., C. Workman, J. Lee, C. Chew, B. M. Dale, L. Colonna, M. Flores, N. Li, E. Schweighoffer, S. Greenberg, et al. 2008. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 180: 5916-5926.